Source: International Congress 2014 – COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Koblizek, J. Zatloukal, M. Plutinsky, P. Safranek, B. Novotna, E. Kocova, M. Vytrisalova, K. Neumannova, A. Vlachova, M. Marel, M. Majerciakova, P. Musilova, B. Snelerova, P. Popelkova, R. Praus, M. Kopecky, L. Pavlikova, T. Dvorak, L. Heribanova, T. Vencalek, K. Hejduk, J. Jarkovsky, J. Svancara, M. Hronek, M. Kovarik, N. Pauk (Hradec Kralove, Olomouc, Brno, Plzen, Praha, Zlin, Jihlava, Usti nad Labem, Ostrava, Liberec, Hradec Králové, Czech Republic). The distribution of phenotypes in a population of severe COPD. Eur Respir J 2014; 44: Suppl. 58, 1938

Member's Comments

No comment yet.

Related content which might interest you: COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Comorbidity at COPD - is actual problem of pulmonology Source: International Congress 2014 – Predictors Year: 2014 Prevalence and characteristics of the asthma-COPD overlap syndrome - or the asthma-like COPD phenotype - in a COPD high risk population Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations Source: International Congress 2014 – COPD markers Year: 2014